Folgen
Abbas Tafakhori
Abbas Tafakhori
Iranian Center of Neurological Research, Tehran University of Medical Sciences
Bestätigte E-Mail-Adresse bei sina.tums.ac.ir
Titel
Zitiert von
Zitiert von
Jahr
Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial
M Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ...
Neurotherapeutics 15 (2), 430-438, 2018
1022018
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial
M Jafarinia, M Afarideh, A Tafakhori, M Arbabi, A Ghajar, AA Noorbala, ...
Journal of affective disorders 204, 1-8, 2016
1012016
The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients
M Abdolahi, A Tafakhori, M Togha, AA Okhovat, F Siassi, MR Eshraghian, ...
Immunogenetics 69, 371-378, 2017
982017
An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic …
A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ...
Neurological Sciences 36, 1121-1126, 2015
892015
Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
E Agah, A Zardoui, A Saghazadeh, M Ahmadi, A Tafakhori, N Rezaei
PLoS One 13 (1), e0190252, 2018
802018
Effects of early intervention of swallowing therapy on recovery from dysphagia following stroke
J Bakhtiyari, P Sarraf, N Nakhostin-Ansari, A Tafakhori, J Logemann, ...
Iranian journal of neurology 14 (3), 119, 2015
782015
Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study
M Amanat, N Rezaei, M Roozbeh, M Shojaei, A Tafakhori, A Zoghi, ...
BMC neurology 21, 1-12, 2021
752021
A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations
S Taghavi, R Chaouni, A Tafakhori, LJ Azcona, SG Firouzabadi, ...
Molecular neurobiology 55, 3477-3489, 2018
742018
Memantine for prophylactic treatment of migraine without aura: A randomized double‐blind placebo‐controlled study
R Noruzzadeh, A Modabbernia, V Aghamollaii, M Ghaffarpour, ...
Headache: The Journal of Head and Face Pain 56 (1), 95-103, 2016
712016
Early versus late spinal decompression surgery in treatment of traumatic spinal cord injuries; a systematic review and meta-analysis
M Yousefifard, V Rahimi-Movaghar, M Baikpour, P Ghelichkhani, ...
Emergency 5 (1), 2017
672017
A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine …
M Abdolahi, P Sarraf, MH Javanbakht, NM Honarvar, M Hatami, N Soveyd, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018
642018
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
S Arabzadeh, E Hakkikazazi, N Shahmansouri, A Tafakhori, A Ghajar, ...
Journal of affective disorders 235, 236-241, 2018
642018
Transplantation of olfactory ensheathing cells on functional recovery and neuropathic pain after spinal cord injury; systematic review and meta-analysis
B Nakhjavan-Shahraki, M Yousefifard, V Rahimi-Movaghar, M Baikpour, ...
Scientific reports 8 (1), 325, 2018
642018
The neuromodulatory effects of ω-3 fatty acids and nano-curcumin on the COX-2/iNOS network in migraines: A clinical trial study from gene expression to clinical symptoms
M Abdolahi, A Jafarieh, P Sarraf, M Sedighiyan, A Yousefi, A Tafakhori, ...
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019
612019
Validation of the Persian version of the brief pain inventory (BPI-P) in chronic pain patients
H Majedi, SS Dehghani, S Soleyman-Jahi, SAE Meibodi, ...
Journal of pain and symptom management 54 (1), 132-138. e2, 2017
532017
The combined effects of ω-3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patients
N Soveyd, M Abdolahi, M Djalali, M Hatami, A Tafakhori, P Sarraf, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017
502017
Identification of a Large DNAJB2 Deletion in a Family with Spinal Muscular Atrophy and Parkinsonism
E Sanchez, H Darvish, R Mesias, S Taghavi, SG Firouzabadi, RH Walker, ...
Human mutation 37 (11), 1180-1189, 2016
452016
Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia
M Wagner, DPS Osborn, I Gehweiler, M Nagel, U Ulmer, S Bakhtiari, ...
Nature communications 10 (1), 4790, 2019
432019
Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism
H Darvish, P Bravo, A Tafakhori, LJ Azcona, S Ranji-Burachaloo, ...
Movement disorders: official journal of the Movement Disorder Society 33 (12 …, 2018
432018
Sensing of Alzheimer’s disease and multiple sclerosis using nano-bio interfaces
MJ Hajipour, F Ghasemi, H Aghaverdi, M Raoufi, U Linne, F Atyabi, ...
Journal of Alzheimer's Disease 59 (4), 1187-1202, 2017
422017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20